anmelden
SMI Expanded
1.972,28
PKT
-10,97
PKT
-0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.04.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 26.04.23 | Novartis Buy | Deutsche Bank AG | |
| 26.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 26.04.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 26.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 25.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 25.04.23 | Richemont Outperform | RBC Capital Markets | |
| 25.04.23 | UBS Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Nestlé Underperform | RBC Capital Markets | |
| 25.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 25.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 25.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 25.04.23 | Nestlé Hold | Jefferies & Company Inc. | |
| 25.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 25.04.23 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.23 | UBS Hold | Jefferies & Company Inc. | |
| 24.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 24.04.23 | Givaudan Sell | UBS AG | |
| 21.04.23 | DocMorris Sell | UBS AG | |
| 21.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 21.04.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 20.04.23 | DocMorris Buy | Warburg Research | |
| 20.04.23 | DocMorris Add | Baader Bank | |
| 20.04.23 | DocMorris Buy | Jefferies & Company Inc. | |
| 19.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 19.04.23 | UBS Sector Perform | RBC Capital Markets | |
| 19.04.23 | Nestlé Overweight | JP Morgan Chase & Co. | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 18.04.23 | Givaudan Underperform | Bernstein Research | |
| 17.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.04.23 | DocMorris Buy | Jefferies & Company Inc. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 17.04.23 | Givaudan Sell | UBS AG | |
| 17.04.23 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.04.23 | Givaudan Neutral | JP Morgan Chase & Co. |
